The $220B Shift: Where Smart Money Is Moving in 2026

Jan de Vries · 2026-10-12

Investment in AI and HealthTech across the EU is exploding. The EU's InvestAI initiative aims to mobilize $220 billion for artificial intelligence, including funding for major AI infrastructure. That's not pocket change—it's a statement. And it's not just public money. The European Commission and the European Investment Bank Group have launched BioTechEU to mobilize $11 billion for biotech and life sciences in 2026 and 2027. Why does this matter to you? Because wealthy private investors are already moving in the same direction. The UBS Global Family Office Report 2026 found that 65% of family offices were invested in AI, and 33% had allocations to AI-enabled healthcare. Let's unpack what's driving this capital rotation. ### The EU's Big Bet on AI and HealthTech The scale of the EU's plans shows how strategically important these sectors have become. Infrastructure is a prime example. In July 2026, the EU requested up to seven AI Gigafactories, backed by up to $11 billion in EU and national funding. These are expected to unlock at least $22 billion in additional private investment across the Union. Life sciences are also a cornerstone of the EU economy—contributing nearly $1.65 trillion in value and supporting 29 million jobs. Through BioTechEU, the EU wants to pour another $11 billion into biotechnology and life sciences during 2026 and 2027. The European Commission's broader life sciences strategy includes measures to make multi-country clinical trials easier to fund and $330 million to stimulate procurement of life sciences innovations, like next-generation vaccines and affordable cancer solutions. As investment flows into these high-growth sectors, investors can explore private-market opportunities through firms like Top Business Ventures, which operates across venture capital, private equity, and real estate markets. ### AI and HealthTech Sector Growth The EU has a massive life sciences industry with major research institutions, healthcare systems, and rapidly expanding AI infrastructure. That helps explain the investor interest. By April 2026, 19 AI Factories had been deployed across European supercomputers, supported by 13 regional AI Factory antennas. These give researchers, startups, and businesses greater access to AI computing capacity. EU and participating EuroHPC countries have committed more than $2.8 billion to the AI Factories and Antennas initiative. Then there's healthcare. The European Health Data Space is designed to make health data easier to access and reuse securely across the EU for research, innovation, and regulatory purposes. This creates potentially valuable infrastructure for medical research and AI development. Other EU projects include building specialist datasets, like Cancer Image Europe, expected to provide access to 60 million cancer images by the end of 2026, and the 1+ Million Genomes initiative, which aims to provide secure access to genomic and associated clinical data. Interestingly, the EU is also moving AI from research into clinical settings. In 2026, the European Commission made $10 million available for two large-scale pilots of AI-powered medical imaging, covering technologies like X-rays, CT scans, MRI, PET, and ultrasound. For investors, the attraction is that HealthTech is moving beyond lab research into real-world clinical testing and EU-backed deployment programs. ### Massive Capital Rotation From High-Net-Worth Investors It's tough to track exactly what every high-net-worth individual is investing in. Much private investment isn't publicly disclosed. But the signals are clear: family offices and wealthy investors are pivoting toward AI and HealthTech. They see the EU's commitment, the infrastructure being built, and the potential for outsized returns. As one family office manager put it: "We're not just chasing hype. We're investing in the backbone of Europe's future." So if you're wondering where the smart money is going in 2026, look no further. The EU is laying the groundwork, and private capital is following.